Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
Abstract Hydroxychloroquine has recently received attention as a treatment for COVID-19. However, it may prolong the QTc interval. Furthermore, when hydroxychloroquine is administered concomitantly with other drugs, it can exacerbate the risk of QT prolongation. Nevertheless, the risk of QT prolonga...
Enregistré dans:
Auteurs principaux: | Byung Jin Choi, Yeryung Koo, Tae Young Kim, Wou Young Chung, Yun Jung Jung, Ji Eun Park, Hong-Seok Lim, Bumhee Park, Dukyong Yoon |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5e76cb6ce35c44c5b3b7684233b37918 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.
par: Sundeep Singh Dhillon, et autres
Publié: (2013) -
Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients
par: Biswadeep Das, et autres
Publié: (2021) -
Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
par: Farrell DF
Publié: (2012) -
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients
par: Juan Jiménez-Jáimez, et autres
Publié: (2020) -
Prescribing errors involving antineoplastics and others drug centre of preparation of injectable drugs
par: Luciana SANTOS, et autres
Publié: (2020)